DOCSLIB.ORG

Mast Cells with Multiple Protease Deficiency Distorted Secretory

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mast Cells with Multiple Protease Deficiency Distorted Secretory Distorted Secretory Granule Composition in Mast Cells with Multiple Protease Deficiency Mirjana Grujic, Gabriela Calounova, Inger Eriksson, Thorsten Feyerabend, Hans-Reimer Rodewald, Elena This information is current as Tchougounova, Lena Kjellén and Gunnar Pejler of October 1, 2021. J Immunol 2013; 191:3931-3938; Prepublished online 23 August 2013; doi: 10.4049/jimmunol.1301441 http://www.jimmunol.org/content/191/7/3931 Downloaded from References This article cites 29 articles, 16 of which you can access for free at: http://www.jimmunol.org/content/191/7/3931.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on October 1, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Distorted Secretory Granule Composition in Mast Cells with Multiple Protease Deficiency Mirjana Grujic,* Gabriela Calounova,*,1 Inger Eriksson,†,1 Thorsten Feyerabend,‡ Hans-Reimer Rodewald,‡ Elena Tchougounova,x Lena Kjelle´n,† and Gunnar Pejler* Mast cells are characterized by an abundance of secretory granules densely packed with inflammatory mediators such as bioactive amines, cytokines, serglycin proteoglycans with negatively charged glycosaminoglycan side chains of either heparin or chondroitin sulfate type, and large amounts of positively charged proteases. Despite the large biological impact of mast cell granules and their contents on various pathologies, the mechanisms that regulate granule composition are incompletely understood. In this study, we hypothesized that granule composition is dependent on a dynamic electrostatic interrelationship between different granule com- pounds. As a tool to evaluate this possibility, we generated mice in which mast cells are multideficient in a panel of positively charged proteases: the chymase mouse mast cell protease-4, the tryptase mouse mast cell protease-6, and carboxypeptidase A3. Through Downloaded from a posttranslational effect, mast cells from these mice additionally lack mouse mast cell protease-5 protein. Mast cells from mice deficient in individual proteases showed normal morphology. In contrast, mast cells with combined protease deficiency displayed a profound distortion of granule integrity, as seen both by conventional morphological criteria and by transmission electron mi- croscopy. An assessment of granule content revealed that the distorted granule integrity in multiprotease-deficient mast cells was associated with a profound reduction of highly negatively charged heparin, whereas no reduction in chondroitin sulfate storage was observed. Taken together with previous findings showing that the storage of basic proteases conversely is regulated by anionic http://www.jimmunol.org/ proteoglycans, these data suggest that secretory granule composition in mast cells is dependent on a dynamic interrelationship between granule compounds of opposite electrical charge. The Journal of Immunology, 2013, 191: 3931–3938. ast cells (MCs) are versatile effector cells of the im- is widely recognized that the preformed granule compounds that mune system, contributing both to adaptive and innate are released upon MC degranulation are key actors in MC-me- M immune responses (1). A hallmark feature of MCs is diated events (1–3). Hence, the MC secretory granules are of cru- their high content of cytoplasmic secretory granules, which con- cial importance for the biological actions of MCs, but despite this stitute the dominating morphological criterion for identifying MCs notion there is only limited knowledge of the mechanisms that regulate their composition. as such. When MCs are activated they can undergo degranulation, by guest on October 1, 2021 a process in which the contents of the secretory granules are re- Serglycin is composed of a small (∼17 kDa) core protein to which leased to the extracellular space (2). The granules contain a panel negatively charged glycosaminoglycans (GAGs) are attached, with of preformed compounds, including bioactive amines (e.g., his- the GAGs attached being of either heparin/heparan sulfate (HS) tamine), preformed cytokines (e.g., TNF), a number of MC- or chondroitin sulfate (CS) type (5). Heparin/HS is built up by re- specific proteases (3, 4), and proteoglycans of serglycin type (5, peating hexuronic acid (HexA)-glucosamine (GlcN) disaccharide 6). Although in many cases the exact mechanisms by which MCs units, where the HexA residues can be either glucuronic acid or contribute in pathological settings are incompletely understood, it iduronic acid and where the GlcN residues can be either N-sulfated or N-acetylated. Additionally, the HexA residues may be 2-O-sul- fated and the GlcN units can carry 6-O- and, rarely, 3-O-sulfate *Department of Anatomy, Physiology, and Biochemistry, Swedish University of groups (7). CS chains are built up by repeating HexA-N-acetylga- Agricultural Sciences, 75123 Uppsala, Sweden; †Department of Medical Biochem- lactosamine (GalNAc) disaccharide units, in which the HexA resi- istry and Microbiology, Uppsala University, 75237 Uppsala, Sweden; ‡Division for Cellular Immunology, German Cancer Research Center, D-69210 Heidelberg, Ger- dues can be 2-O-sulfated and the GalNAc residues may carry 4-O- many; and xDepartment of Immunology, Genetics, and Pathology, Rudbeck Labora- and/or 6-O-sulfate groups (8). Importantly, both heparin/HS and CS tory, Uppsala University, 75185 Uppsala, Sweden exhibit a large extent of heterogeneity, both with regard to chain 1G.C. and I.E. contributed equally to this work. length and to the extent and pattern of sulfation (7, 8). Received for publication May 31, 2013. Accepted for publication July 1, 2013. In previous studies we have shown that serglycin proteoglycan This work was supported by grants from the Swedish Research Council, the Swedish promotes the storage of a number of positively charged secretory Cancer Foundation, and by Formas and King Gustaf V’s 80-Year Anniversary Fund. granule–localized MC proteases, including chymases (mouse MC H.-R.R. received support from European Research Council Advanced Grant 233074 and Sonderforschungsbereich Grant 938-project L. protease [mMCP]-4 and mMCP-5), tryptase (mMCP-6), and car- Address correspondence and reprint requests to Prof. Gunnar Pejler, Swedish Uni- boxypeptidase A3 (CPA3) (3, 4, 9, 10). A likely explanation for versity of Agricultural Sciences, Department of Anatomy, Physiology and Biochem- these observations is that negatively charged GAG chains attached istry, BMC, Box 575, 75123 Uppsala, Sweden. E-mail address: [email protected] to the serglycin core protein interact electrostatically with positive Abbreviations used in this article: BMMC, bone marrow–derived mast cell; CPA, charge displayed by its binding partners, that is, the proteases (5, carboxypeptidase; CS, chondroitin sulfate; GAG, glycosaminoglycan; GalNAc, N- acetylgalactosamine; GlcN, glucosamine; HexA, hexuronic acid; HS, heparan sul- 6). Although these findings have established a role for negatively fate; KO, knockout; MC, mast cell; mMCP, mouse mast cell protease; PCMC, peri- charged proteoglycans of serglycin type in regulating the storage toneal cell–derived mast cell; RPIP, reverse-phase ion-pair; TEM, transmission of granule compounds in MCs, little is known of the dynamics in electron microscopy; WT, wild-type. regulating MC secretory granule composition. For example, one Copyright Ó 2013 by The American Association of Immunologists, Inc. 0022-1767/13/$16.00 important question is whether there is an interdependence of the www.jimmunol.org/cgi/doi/10.4049/jimmunol.1301441 3932 PROTEASE-DEFICIENT MAST CELLS various granule compounds such that a reduction of positive DNA was removed by centrifugation (2000 3 g, 10 min, 4˚C) and smaller charge will affect the granule composition in an analogous fashion DNA fragments were further digested by 300 U DNAse I from bovine as does the reduction in negative charge density. To address this pancreas (Sigma-Aldrich). The lysed cells were subsequently applied to DEAE Sephacel columns. Bound proteoglycans were eluted with PBS/3 M issue, in this study we generated mice deficient in multiple posi- NaCl/0.5% Triton X-100, and 10 ml of each fraction (300 ml/fraction) was tively charged proteases that are stored within MC granules, that mixed with 2 ml OptiPhase HiSafe 3 scintillation mixture and analyzed by is, mMCP-4, mMCP-5, mMCP-6, and CPA3. Indeed, we show scintillation counting. Fractions containing [35S]-labeled proteoglycans that the absence of multiple MC proteases results in severe effects were pooled, desalted through PD10 columns (GE Healthcare), and treated with 0.5 M NaOH overnight at 4˚C to release free GAG chains from the on granule integrity, as reflected by distorted granule staining proteoglycans. The samples were neutralized
Load more

Recommended publications
  • Tumor Elastography and Its Association with Cell-Free Tumor DNA in the Plasma of Breast Tumor Patients: a Pilot Study
    3534 Original Article Tumor elastography and its association with cell-free tumor DNA in the plasma of breast tumor patients: a pilot study Yi Hao1#, Wei Yang2#, Wenyi Zheng2,3#, Xiaona Chen3,4, Hui Wang1,5, Liang Zhao1,5, Jinfeng Xu6,7, Xia Guo4 1Department of Ultrasound, South China Hospital of Shenzhen University, Shenzhen, China; 2Department of Ultrasound, Shenzhen Hospital, Southern Medical University, Shenzhen, China; 3The Third School of Clinical Medicine, Southern Medical University, Guangzhou, China; 4Shenzhen Key Laboratory of Viral Oncology, Center for Clinical Research and Innovation (CCRI), Shenzhen Hospital, Southern Medical University, Shenzhen, China; 5Department of Ultrasound, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China; 6Department of Ultrasound, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University, Shenzhen, China; 7The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China #These authors contributed equally to this work. Correspondence to: Xia Guo. Shenzhen Key Laboratory of Viral Oncology, Center for Clinical Research and Innovation (CCRI), Shenzhen Hospital, Southern Medical University, Shenzhen 518000, China. Email: [email protected]; Jinfeng Xu. Department of Ultrasound, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University, Shenzhen 518020, China; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, China. Email: [email protected]. Background: Breast tumor stiffness, which can be objectively and noninvasively evaluated by ultrasound elastography (UE), has been useful for the differentiation of benign and malignant breast lesions and the prediction of clinical outcomes. Liquid biopsy analyses, including cell-free tumor DNA (ctDNA), exhibit great potential for personalized treatment. This study aimed to investigate the correlations between the UE and ctDNA for early breast cancer diagnosis.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Assembly of an Integrated Human Lung Cell Atlas Reveals That
    medRxiv preprint doi: https://doi.org/10.1101/2020.06.02.20120634; this version posted June 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Assembly of an integrated human lung cell atlas reveals that SARS-CoV-2 receptor is co-expressed with key elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells Davi Sidarta-Oliveira1,2, Carlos Poblete Jara1,3, Adriano J. Ferruzzi4, Munir S. Skaf4, William H. Velander5, Eliana P. Araujo1,3, Licio A. Velloso1 1Laboratory of Cell Signaling, Obesity and Comorbidities Research Center, University of Campinas, Brazil 2 Physician-Scientist Graduate Program, School of Medical Sciences, University of Campinas, Brazil 3Nursing School, University of Campinas, Brazil 4Institute of Chemistry and Center for Computing in Engineering and Sciences University of Campinas, Brazil 5Department of Chemical and Biomolecular Engineering, University of Nebraska, Lincoln, USA Correspondence: Licio A. Velloso Laboratory of Cell Signaling, Obesity and Comorbidities Research Center, University of Campinas, Campinas, Brazil Address: Rua Carl Von Lineaus s/n, Instituto de Biologia - Bloco Z. Campus Universitário Zeferino Vaz - Barão Geraldo, Campinas - SP, 13083-864 Phone: +55 19 3521-0025 E-mail: [email protected] Abstract SARS-CoV-2, the pathogenic agent of COVID-19, employs angiotensin converting enzyme-2 (ACE2) as its cell entry receptor. Clinical data reveal that in severe COVID- 19, SARS-CoV-2 infects the lung, leading to a frequently lethal triad of respiratory insufficiency, acute cardiovascular failure, and coagulopathy.
    [Show full text]
  • How Relevant Are Bone Marrow-Derived Mast Cells (Bmmcs) As Models for Tissue Mast Cells? a Comparative Transcriptome Analysis of Bmmcs and Peritoneal Mast Cells
    cells Article How Relevant Are Bone Marrow-Derived Mast Cells (BMMCs) as Models for Tissue Mast Cells? A Comparative Transcriptome Analysis of BMMCs and Peritoneal Mast Cells 1, 2, 1 1 2,3 Srinivas Akula y , Aida Paivandy y, Zhirong Fu , Michael Thorpe , Gunnar Pejler and Lars Hellman 1,* 1 Department of Cell and Molecular Biology, Uppsala University, The Biomedical Center, Box 596, SE-751 24 Uppsala, Sweden; [email protected] (S.A.); [email protected] (Z.F.); [email protected] (M.T.) 2 Department of Medical Biochemistry and Microbiology, Uppsala University, The Biomedical Center, Box 589, SE-751 23 Uppsala, Sweden; [email protected] (A.P.); [email protected] (G.P.) 3 Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Box 7011, SE-75007 Uppsala, Sweden * Correspondence: [email protected]; Tel.: +46-(0)18-471-4532; Fax: +46-(0)18-471-4862 These authors contributed equally to this work. y Received: 29 July 2020; Accepted: 16 September 2020; Published: 17 September 2020 Abstract: Bone marrow-derived mast cells (BMMCs) are often used as a model system for studies of the role of MCs in health and disease. These cells are relatively easy to obtain from total bone marrow cells by culturing under the influence of IL-3 or stem cell factor (SCF). After 3 to 4 weeks in culture, a nearly homogenous cell population of toluidine blue-positive cells are often obtained. However, the question is how relevant equivalents these cells are to normal tissue MCs. By comparing the total transcriptome of purified peritoneal MCs with BMMCs, here we obtained a comparative view of these cells.
    [Show full text]
  • 1 No. Affymetrix ID Gene Symbol Genedescription Gotermsbp Q Value 1. 209351 at KRT14 Keratin 14 Structural Constituent of Cyto
    1 Affymetrix Gene Q No. GeneDescription GOTermsBP ID Symbol value structural constituent of cytoskeleton, intermediate 1. 209351_at KRT14 keratin 14 filament, epidermis development <0.01 biological process unknown, S100 calcium binding calcium ion binding, cellular 2. 204268_at S100A2 protein A2 component unknown <0.01 regulation of progression through cell cycle, extracellular space, cytoplasm, cell proliferation, protein kinase C inhibitor activity, protein domain specific 3. 33323_r_at SFN stratifin/14-3-3σ binding <0.01 regulation of progression through cell cycle, extracellular space, cytoplasm, cell proliferation, protein kinase C inhibitor activity, protein domain specific 4. 33322_i_at SFN stratifin/14-3-3σ binding <0.01 structural constituent of cytoskeleton, intermediate 5. 201820_at KRT5 keratin 5 filament, epidermis development <0.01 structural constituent of cytoskeleton, intermediate 6. 209125_at KRT6A keratin 6A filament, ectoderm development <0.01 regulation of progression through cell cycle, extracellular space, cytoplasm, cell proliferation, protein kinase C inhibitor activity, protein domain specific 7. 209260_at SFN stratifin/14-3-3σ binding <0.01 structural constituent of cytoskeleton, intermediate 8. 213680_at KRT6B keratin 6B filament, ectoderm development <0.01 receptor activity, cytosol, integral to plasma membrane, cell surface receptor linked signal transduction, sensory perception, tumor-associated calcium visual perception, cell 9. 202286_s_at TACSTD2 signal transducer 2 proliferation, membrane <0.01 structural constituent of cytoskeleton, cytoskeleton, intermediate filament, cell-cell adherens junction, epidermis 10. 200606_at DSP desmoplakin development <0.01 lectin, galactoside- sugar binding, extracellular binding, soluble, 7 space, nucleus, apoptosis, 11. 206400_at LGALS7 (galectin 7) heterophilic cell adhesion <0.01 2 S100 calcium binding calcium ion binding, epidermis 12. 205916_at S100A7 protein A7 (psoriasin 1) development <0.01 S100 calcium binding protein A8 (calgranulin calcium ion binding, extracellular 13.
    [Show full text]
  • Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients with Stable Coronary Heart Disease
    Supplementary Online Content Ganz P, Heidecker B, Hveem K, et al. Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease. JAMA. doi: 10.1001/jama.2016.5951 eTable 1. List of 1130 Proteins Measured by Somalogic’s Modified Aptamer-Based Proteomic Assay eTable 2. Coefficients for Weibull Recalibration Model Applied to 9-Protein Model eFigure 1. Median Protein Levels in Derivation and Validation Cohort eTable 3. Coefficients for the Recalibration Model Applied to Refit Framingham eFigure 2. Calibration Plots for the Refit Framingham Model eTable 4. List of 200 Proteins Associated With the Risk of MI, Stroke, Heart Failure, and Death eFigure 3. Hazard Ratios of Lasso Selected Proteins for Primary End Point of MI, Stroke, Heart Failure, and Death eFigure 4. 9-Protein Prognostic Model Hazard Ratios Adjusted for Framingham Variables eFigure 5. 9-Protein Risk Scores by Event Type This supplementary material has been provided by the authors to give readers additional information about their work. Downloaded From: https://jamanetwork.com/ on 10/02/2021 Supplemental Material Table of Contents 1 Study Design and Data Processing ......................................................................................................... 3 2 Table of 1130 Proteins Measured .......................................................................................................... 4 3 Variable Selection and Statistical Modeling ........................................................................................
    [Show full text]
  • Peripheral Regulation of Pain and Itch
    Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1596 Peripheral Regulation of Pain and Itch ELÍN INGIBJÖRG MAGNÚSDÓTTIR ACTA UNIVERSITATIS UPSALIENSIS ISSN 1651-6206 ISBN 978-91-513-0746-6 UPPSALA urn:nbn:se:uu:diva-392709 2019 Dissertation presented at Uppsala University to be publicly examined in A1:107a, BMC, Husargatan 3, Uppsala, Friday, 25 October 2019 at 13:00 for the degree of Doctor of Philosophy (Faculty of Medicine). The examination will be conducted in English. Faculty examiner: Professor emeritus George H. Caughey (University of California, San Francisco). Abstract Magnúsdóttir, E. I. 2019. Peripheral Regulation of Pain and Itch. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1596. 71 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-513-0746-6. Pain and itch are diverse sensory modalities, transmitted by the somatosensory nervous system. Stimuli such as heat, cold, mechanical pain and itch can be transmitted by different neuronal populations, which show considerable overlap with regards to sensory activation. Moreover, the immune and nervous systems can be involved in extensive crosstalk in the periphery when reacting to these stimuli. With recent advances in genetic engineering, we now have the possibility to study the contribution of distinct neuron types, neurotransmitters and other mediators in vivo by using gene knock-out mice. The neuropeptide calcitonin gene-related peptide (CGRP) and the ion channel transient receptor potential cation channel subfamily V member 1 (TRPV1) have both been implicated in pain and itch transmission. In Paper I, the Cre- LoxP system was used to specifically remove CGRPα from the primary afferent population that expresses TRPV1.
    [Show full text]
  • Supplementary Table 1
    Supplementary Table 1. 492 genes are unique to 0 h post-heat timepoint. The name, p-value, fold change, location and family of each gene are indicated. Genes were filtered for an absolute value log2 ration 1.5 and a significance value of p ≤ 0.05. Symbol p-value Log Gene Name Location Family Ratio ABCA13 1.87E-02 3.292 ATP-binding cassette, sub-family unknown transporter A (ABC1), member 13 ABCB1 1.93E-02 −1.819 ATP-binding cassette, sub-family Plasma transporter B (MDR/TAP), member 1 Membrane ABCC3 2.83E-02 2.016 ATP-binding cassette, sub-family Plasma transporter C (CFTR/MRP), member 3 Membrane ABHD6 7.79E-03 −2.717 abhydrolase domain containing 6 Cytoplasm enzyme ACAT1 4.10E-02 3.009 acetyl-CoA acetyltransferase 1 Cytoplasm enzyme ACBD4 2.66E-03 1.722 acyl-CoA binding domain unknown other containing 4 ACSL5 1.86E-02 −2.876 acyl-CoA synthetase long-chain Cytoplasm enzyme family member 5 ADAM23 3.33E-02 −3.008 ADAM metallopeptidase domain Plasma peptidase 23 Membrane ADAM29 5.58E-03 3.463 ADAM metallopeptidase domain Plasma peptidase 29 Membrane ADAMTS17 2.67E-04 3.051 ADAM metallopeptidase with Extracellular other thrombospondin type 1 motif, 17 Space ADCYAP1R1 1.20E-02 1.848 adenylate cyclase activating Plasma G-protein polypeptide 1 (pituitary) receptor Membrane coupled type I receptor ADH6 (includes 4.02E-02 −1.845 alcohol dehydrogenase 6 (class Cytoplasm enzyme EG:130) V) AHSA2 1.54E-04 −1.6 AHA1, activator of heat shock unknown other 90kDa protein ATPase homolog 2 (yeast) AK5 3.32E-02 1.658 adenylate kinase 5 Cytoplasm kinase AK7
    [Show full text]
  • Asthma Experimental Involved in the Development of Mouse Mast Cell Protease-6 and MHC
    Mouse Mast Cell Protease-6 and MHC Are Involved in the Development of Experimental Asthma This information is current as Yue Cui, Joakim S. Dahlin, Ricardo Feinstein, Lora G. of September 28, 2021. Bankova, Wei Xing, Kichul Shin, Michael F. Gurish and Jenny Hallgren J Immunol 2014; 193:4783-4789; Prepublished online 15 October 2014; doi: 10.4049/jimmunol.1302947 Downloaded from http://www.jimmunol.org/content/193/10/4783 References This article cites 33 articles, 16 of which you can access for free at: http://www.jimmunol.org/content/193/10/4783.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 28, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2014 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Mouse Mast Cell Protease-6 and MHC Are Involved in the Development of Experimental Asthma Yue Cui,*,1 Joakim S. Dahlin,*,1 Ricardo Feinstein,† Lora G.
    [Show full text]
  • The Emerging Role of Mast Cell Proteases in Asthma
    REVIEW ASTHMA The emerging role of mast cell proteases in asthma Gunnar Pejler1,2 Affiliations: 1Dept of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden. 2Dept of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Uppsala, Sweden. Correspondence: Gunnar Pejler, Dept of Medical Biochemistry and Microbiology, BMC, Uppsala University, Box 582, 75123 Uppsala, Sweden. E-mail: [email protected] @ERSpublications Mast cells express large amounts of proteases, including tryptase, chymase and carboxypeptidase A3. An extensive review of how these proteases impact on asthma shows that they can have both protective and detrimental functions. http://bit.ly/2Gu1Qp2 Cite this article as: Pejler G. The emerging role of mast cell proteases in asthma. Eur Respir J 2019; 54: 1900685 [https://doi.org/10.1183/13993003.00685-2019]. ABSTRACT It is now well established that mast cells (MCs) play a crucial role in asthma. This is supported by multiple lines of evidence, including both clinical studies and studies on MC-deficient mice. However, there is still only limited knowledge of the exact effector mechanism(s) by which MCs influence asthma pathology. MCs contain large amounts of secretory granules, which are filled with a variety of bioactive compounds including histamine, cytokines, lysosomal hydrolases, serglycin proteoglycans and a number of MC-restricted proteases. When MCs are activated, e.g. in response to IgE receptor cross- linking, the contents of their granules are released to the exterior and can cause a massive inflammatory reaction. The MC-restricted proteases include tryptases, chymases and carboxypeptidase A3, and these are expressed and stored at remarkably high levels.
    [Show full text]
  • Mast Cell Secretory Granules: Armed for Battle
    REVIEWS Mast cell secretory granules: armed for battle Sara Wernersson and Gunnar Pejler Abstract | Mast cells are important effector cells of the immune system and recent studies show that they have immunomodulatory roles in diverse processes in both health and disease. Mast cells are distinguished by their high content of electron-dense secretory granules, which are filled with large amounts of preformed and pre-activated immunomodulatory compounds. When appropriately activated, mast cells undergo degranulation, a process by which these preformed granule compounds are rapidly released into the surroundings. In many cases, the effects that mast cells have on an immune response are closely associated with the biological actions of the granule compounds that they release, as exemplified by the recent studies showing that mast cell granule proteases account for many of the protective and detrimental effects of mast cells in various inflammatory settings. In this Review, we discuss the current knowledge of mast cell secretory granules. Tr y p ta s e s Mast cells are haematopoietic cells that arise from pluri- The secretory granules of mast cells are filled with a 1–3 Serine proteases that have potent precursors of the bone marrow . After egression large panel of preformed compounds (TABLE 1). When trypsin-like cleavage from the bone marrow, mast cell progenitors circu- mast cells are activated to degranulate, these com- specificities — that is, they late in the blood before they enter various tissues and pounds are released into the extracellular environment cleave peptide bonds on the develop into mature mast cells under the influence of and can have a marked effect on any physiological or carboxy-terminal side of arginine or lysine residues.
    [Show full text]
  • Download PDF File
    CLINICAL CARDIOLOGY Cardiology Journal 2019, Vol. 26, No. 6, 680–686 DOI: 10.5603/CJ.a2018.0018 Copyright © 2019 Via Medica ORIGINAL ARTICLE ISSN 1897–5593 Mast cell derived carboxypeptidase A3 is decreased among patients with advanced coronary artery disease Łukasz Lewicki1, 2, 3, Janusz Siebert1, 4, Tomasz Koliński5, Karolina Piekarska5, Magdalena Reiwer-Gostomska4, Radosław Targoński3, Piotr Trzonkowski6, Natalia Marek-Trzonkowska5 1University Center for Cardiology, Gdansk, Poland 2Department of Machine Design and Automotive Engineering, Faculty of Mechanical Engineering, Gdansk University of Technology, Gdansk, Poland 3Pomeranian Cardiology Centers, Wejherowo, Poland 4Department of Family Medicine, Medical University of Gdansk, Poland 6Department of Family Medicine, Laboratory of Immunoregulation and Cellular Therapies, Medical University of Gdansk, Poland 7Department of Clinical Immunology and Transplantology, Medical University of Gdansk, Poland Abstract Background: Coronary artery disease (CAD) affects milions of people and can result in myocardial infarction (MI). Previously, mast cells (MC) have been extensively investigated in the context of hyper- sensitivity, however as regulators of the local inflammatory response they can potentially contribute to CAD and/or its progression. The aim of the study was to assess if serum concentration of MC proteases: carboxypeptidase A3, cathepsin G and chymase 1 is associated with the extension of CAD and MI. Methods: The 44 patients with angiographically confirmed CAD (23 subjects with non-ST-segment elevation MI [NSTEMI] and 21 with stable CAD) were analyzed. Clinical data were obtained as well serum concentrations of carboxypeptidase A3, cathepsin G and chymase 1 were also measured. Results: Patients with single vessel CAD had higher serum concentration of carboxypeptidase than those with more advanced CAD (3838.6 ± 1083.1 pg/mL vs.
    [Show full text]